CN112105728A - CRISPR/Cas效应蛋白及系统 - Google Patents

CRISPR/Cas效应蛋白及系统 Download PDF

Info

Publication number
CN112105728A
CN112105728A CN201980030881.2A CN201980030881A CN112105728A CN 112105728 A CN112105728 A CN 112105728A CN 201980030881 A CN201980030881 A CN 201980030881A CN 112105728 A CN112105728 A CN 112105728A
Authority
CN
China
Prior art keywords
sequence
protein
nucleic acid
seq
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201980030881.2A
Other languages
English (en)
Other versions
CN112105728B (zh
Inventor
赖锦盛
周英思
朱金洁
张湘博
赵海铭
宋伟彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Agricultural University
Original Assignee
China Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Agricultural University filed Critical China Agricultural University
Publication of CN112105728A publication Critical patent/CN112105728A/zh
Application granted granted Critical
Publication of CN112105728B publication Critical patent/CN112105728B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

涉及核酸编辑领域,特别是规律成簇的间隔短回文重复(CRISPR)技术领域。一种Cas效应蛋白,包含此类蛋白的融合蛋白,以及编码它们的核酸分子。提供了用于核酸编辑(例如,基因或基因组编辑)的复合物和组合物,其包含上述蛋白或融合蛋白,或编码它们的核酸分子。用于核酸编辑(例如,基因或基因组编辑)的方法,其使用包含上述的蛋白或融合蛋白。

Description

PCT国内申请,说明书已公开。

Claims (35)

  1. PCT国内申请,权利要求书已公开。
CN201980030881.2A 2018-05-07 2019-05-07 CRISPR/Cas效应蛋白及系统 Active CN112105728B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2018104266661 2018-05-07
CN201810426666 2018-05-07
PCT/CN2019/085826 WO2019214604A1 (zh) 2018-05-07 2019-05-07 CRISPR/Cas效应蛋白及系统

Publications (2)

Publication Number Publication Date
CN112105728A true CN112105728A (zh) 2020-12-18
CN112105728B CN112105728B (zh) 2023-01-10

Family

ID=68467143

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980030881.2A Active CN112105728B (zh) 2018-05-07 2019-05-07 CRISPR/Cas效应蛋白及系统

Country Status (2)

Country Link
CN (1) CN112105728B (zh)
WO (1) WO2019214604A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022266849A1 (zh) * 2021-06-22 2022-12-29 中国科学院脑科学与智能技术卓越创新中心 新型CRISPR-Cas13蛋白的筛选及其应用
CN116286742A (zh) * 2022-09-29 2023-06-23 隆平生物技术(海南)有限公司 CasD蛋白、CRISPR/CasD基因编辑系统及其在植物基因编辑中的应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020002647A2 (pt) * 2017-08-09 2020-08-18 Benson Hill, Inc. composições e métodos para modificação de genomas
MX2021005723A (es) * 2018-11-15 2021-09-23 Univ China Agricultural Enzima y sistema crispr-cas12j.
CA3130789A1 (en) * 2019-03-07 2020-09-10 The Regents Of The University Of California Crispr-cas effector polypeptides and methods of use thereof
US20230045187A1 (en) * 2019-12-04 2023-02-09 Arbor Biotechnologies, Inc. Compositions comprising a nuclease and uses thereof
CA3179130A1 (en) 2020-06-04 2021-12-09 Lior IZHAR Novel omni-59, 61, 67, 76, 79, 80, 81, and 82 crispr nucleases
CN114277015B (zh) * 2021-03-16 2023-12-15 山东舜丰生物科技有限公司 Crispr酶以及应用
CN115261359B (zh) * 2021-05-21 2023-06-30 山东舜丰生物科技有限公司 一种新型crispr酶和系统以及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140349405A1 (en) * 2013-05-22 2014-11-27 Wisconsin Alumni Research Foundation Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis
US20160102322A1 (en) * 2014-10-09 2016-04-14 Life Technologies Corporation Crispr oligonucleotides and gene editing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105907785B (zh) * 2016-05-05 2020-02-07 苏州吉玛基因股份有限公司 化学合成的crRNA用于CRISPR/Cpf1系统在基因编辑中的应用
CN107784200B (zh) * 2016-08-26 2020-11-06 深圳华大生命科学研究院 一种筛选新型CRISPR-Cas系统的方法和装置
EA201990860A1 (ru) * 2016-09-30 2019-10-31 Рнк-направляемые модифицирующие нуклеиновые кислоты ферменты и способы их применения

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140349405A1 (en) * 2013-05-22 2014-11-27 Wisconsin Alumni Research Foundation Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis
US20160102322A1 (en) * 2014-10-09 2016-04-14 Life Technologies Corporation Crispr oligonucleotides and gene editing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WINSTON X. YAN等: "Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL domain-containing accessory protein", 《MOL CELL.》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022266849A1 (zh) * 2021-06-22 2022-12-29 中国科学院脑科学与智能技术卓越创新中心 新型CRISPR-Cas13蛋白的筛选及其应用
CN116286742A (zh) * 2022-09-29 2023-06-23 隆平生物技术(海南)有限公司 CasD蛋白、CRISPR/CasD基因编辑系统及其在植物基因编辑中的应用
CN116286742B (zh) * 2022-09-29 2023-11-17 隆平生物技术(海南)有限公司 CasD蛋白、CRISPR/CasD基因编辑系统及其在植物基因编辑中的应用

Also Published As

Publication number Publication date
CN112105728B (zh) 2023-01-10
WO2019214604A1 (zh) 2019-11-14

Similar Documents

Publication Publication Date Title
CN113136375B (zh) 新型CRISPR/Cas12f酶和系统
CN111770992A (zh) CRISPR-Cas12j酶和系统
CN112105728A (zh) CRISPR/Cas效应蛋白及系统
US10781432B1 (en) Engineered cascade components and cascade complexes
CN112004932B (zh) 一种CRISPR/Cas效应蛋白及系统
CN113015798B (zh) CRISPR-Cas12a酶和系统
CN114517190B (zh) Crispr酶和系统以及应用
CN114438055B (zh) 新型的crispr酶和系统以及应用
WO2019206233A1 (zh) 一种RNA编辑的CRISPR/Cas效应蛋白及系统
CN117106752A (zh) 优化的Cas12蛋白及其应用
CN113930410A (zh) 新型CRISPR-Cas12L酶和系统
CN113930411A (zh) 新型CRISPR-Cas12M酶和系统
CN114277015A (zh) 新型crispr酶以及应用
CN113930412A (zh) 新型CRISPR-Cas12N酶和系统
CN113930413A (zh) 新型CRISPR-Cas12j.23酶和系统
WO2023143150A1 (zh) 新型Cas酶和系统以及应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant